Information on the platimum-based chemotherapy agent cisplatin  
 
site index:
Cisplatin
How it Works
Cisplatin Treatment
Side Effects of Cisplatin
Research
Other Resources
About Us
 
 
 

Research


Meta-analysis finds cisplatin improves post-operative survival in patients with non-small lung cancer.

ASCO 2008 meeting: Cetuximab plus platinum chemotherapy agents effective treatment for lung cancer.

Also for head and neck cancers.


Resistance to Cisplatin - due to copper transporter - National Institute of General Medical Sciences

Cisplatin-Based Chemotherapy Improves Survival in Non-Small Cell Lung Cancer - National Cancer Institute

Meta-Analysis Suggests Cisplatin Superior to Carboplatin for Advanced NSCLC - NCI Clinical Trial result

Long-Term Data Support Cisplatin-Based Chemoradiation for Cervical Cancer - NCI Clinical Trial result

Cisplatin-Based Chemotherapy Improves Survival in Non-Small Cell Lung Cancer - Clinical trial result

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer

Antitumor activity of the combination of synthetic retinoid ST1926 and cisplatin in ovarian carcinoma models.

Other web resources about cisplatin

 




© 2008 cisplatin.org